logo

Impel Pharmaceuticals Inc. (IMPL)



Trade IMPL now with
  Date
  Headline
9/10/2021 10:46:22 AM Impel NeuroPharma Shares Slip 20%
9/3/2021 9:28:04 AM Impel NeuroPharma: FDA Approves TRUDHESA Nasal Spray For Acute Treatment Of Migraine
8/16/2021 8:13:45 AM Impel NeuroPharma Q2 GAAP Net Loss Per Share $1.10; Non-GAAP Net Loss Per Share $0.79